Relationship between chronic kidney disease and adverse outcomes of coronavirus disease 2019: a meta-analysis based on adjusted risk estimates
W Xiao, J Xu, X Liang, L Shi, P Zhang, Y Wang… - … Urology and Nephrology, 2021 - Springer
Recently, there are several studies reporting that pre-existing chronic kidney disease (CKD)
was related to the adverse outcomes of patients with coronavirus disease 2019 (COVID …
was related to the adverse outcomes of patients with coronavirus disease 2019 (COVID …
Chronic Kidney Disease and COVID-19: Outcomes of hospitalised adults from a tertiary care centre in North India
Abstract Background Coronavirus disease 2019 (COVID-19) is a novel disease caused by
the SARS-CoV-2 virus and has emerged as a deadly pandemic affecting countries all over …
the SARS-CoV-2 virus and has emerged as a deadly pandemic affecting countries all over …
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort …
M Drysdale, H Tibble, V Patel, DC Gibbons… - BMC Infectious …, 2024 - Springer
Background The clinical benefit of coronavirus disease 2019 (COVID-19) treatments against
new circulating variants remains unclear. We sought to describe characteristics and clinical …
new circulating variants remains unclear. We sought to describe characteristics and clinical …
Pharmacotherapy for Patients with Chronic Kidney Disease during the COVID-19: A Narrative Review
MA Mahmoud - Journal of Advances in Medicine and …, 2021 - eprint.subtopublish.com
Background: COVID-19 is considered the most challenging global pandemic. Patients with
COVID-19 are more vulnerable to renal impairment especially those admitted to the …
COVID-19 are more vulnerable to renal impairment especially those admitted to the …
Remdesivir in COVID-19 Patients with Kidney Disease: A Study on the Renal Function and Outcomes: TH-PO1098
CG Lagura, JI Togonon-Leaño - Journal of the American Society of …, 2023 - journals.lww.com
Background: The COVID-19 pandemic has high mortality rates in patients with kidney
disease. Remdesivir, an antiviral nucleotide prodrug, showed to shorten time to recovery in …
disease. Remdesivir, an antiviral nucleotide prodrug, showed to shorten time to recovery in …
Management of COVID-19 in special populations with kidney disease.
Y Radhakrishnan, M Hassanein… - Cleveland Clinic Journal …, 2020 - europepmc.org
Although the literature is limited, early evidence suggests that patients with chronic kidney
disease, end-stage kidney disease, and kidney transplant recipients are at increased risk for …
disease, end-stage kidney disease, and kidney transplant recipients are at increased risk for …
Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States
JE Flythe, MM Assimon, MJ Tugman, EH Chang… - American Journal of …, 2021 - Elsevier
Rationale & Objective Underlying kidney disease is an emerging risk factor for more severe
coronavirus disease 2019 (COVID-19) illness. We examined the clinical courses of critically …
coronavirus disease 2019 (COVID-19) illness. We examined the clinical courses of critically …
[HTML][HTML] COVID-19 pandemic causing acute kidney injury and impact on patients with chronic kidney disease and renal transplantation
Abstract Coronavirus disease 2019 (COVID-19) caused by 2019 novel coronavirus (2019-
nCoV) has caused significant mortality and has been declared as a global pandemic by the …
nCoV) has caused significant mortality and has been declared as a global pandemic by the …
Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European …
M Hilhorst, FJ Bemelman, A Bruchfeld… - Nephrology Dialysis …, 2023 - academic.oup.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic led to rapid
vaccine development and large global vaccination schemes. However, patients with …
vaccine development and large global vaccination schemes. However, patients with …
Drug–drug interaction of nirmatrelvir/ritonavir and tacrolimus: a potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERS
F Qin, H Wang, M Li, S Zhuo, W Liu - Expert Opinion on Drug Safety, 2023 - Taylor & Francis
Background Nirmatrelvir/ritonavir is a new oral antiviral agent for COVID-19, and tacrolimus
is a widely used immunosuppressant. Drug–drug interaction between Nirmatrelvir/ritonavir …
is a widely used immunosuppressant. Drug–drug interaction between Nirmatrelvir/ritonavir …